(Q31047729)

28 June 2017

title

Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'. (English)

1 reference

28 June 2017

1 reference

R M Barnes

1

1 reference

28 June 2017

L Gee

2

1 reference

28 June 2017

S Taylor

3

1 reference

28 June 2017

M C Briggs

4

1 reference

28 June 2017

S P Harding

5

1 reference

28 June 2017

publication date

1 August 2004

1 reference

28 June 2017

1 reference

28 June 2017

volume

18

1 reference

28 June 2017

issue

8

1 reference

28 June 2017

page(s)

809-813

1 reference

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

Verteporfin photodynamic therapy in the UK: implications of the NICE appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

7 January 2021

The prevalence of age-related maculopathy in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

7 January 2021

Age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

7 January 2021

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

7 January 2021

Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

7 January 2021

The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701329

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6701329

1 reference

Dimensions Publication ID

28 June 2017

1010972319

0 references

1 reference